<DOC>
	<DOCNO>NCT02948660</DOCNO>
	<brief_summary>The research contain three part . Part 1 : To explore evaluate prognostic value electroencephalography sleep cycle combine serum melatonin orexin level patient disorder consciousness ; Part 2 : To assess efficacy wake-promoting function zolpidem tartrate comotase patient ; Part 3 : To assess efficacy wake-promoting function melatonin comotase patient .</brief_summary>
	<brief_title>The Role Sleep-modulating Drugs Recovery Patients With Disorders Consciousness</brief_title>
	<detailed_description />
	<mesh_term>Consciousness Disorders</mesh_term>
	<mesh_term>Zolpidem</mesh_term>
	<mesh_term>Melatonin</mesh_term>
	<criteria>Glasgow Coma Scale score &lt; =8 vital sign stable history use sedative anesthetic premorbid history developmental , psychiatric , neurological illness result documented functional disability time injury severe coexist systemic disease limit life expectancy EEG show nonconvulsive status epilepticus</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>